+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Olanzapine"

From
Mental Illness Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Mental Illness Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 92 Pages
  • China
From
From
LYBALVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYBALVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
Schizophrenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Schizophrenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
From
From
From
Mental Illness Drugs Markets in China - Product Thumbnail Image

Mental Illness Drugs Markets in China

  • Report
  • March 2025
  • 251 Pages
  • China
From
From
From
Loading Indicator

Olanzapine is a medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and depression. It is a member of the atypical antipsychotic class of drugs, which are used to treat the symptoms of mental health conditions. Olanzapine works by blocking certain receptors in the brain, which helps to reduce the symptoms of mental health conditions. It is also used to treat agitation and aggression in people with dementia. Olanzapine is a widely used medication in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, and is often prescribed as a first-line treatment for schizophrenia. It is also used to treat other mental health conditions, such as bipolar disorder and depression. Olanzapine is generally well-tolerated, and has fewer side effects than other antipsychotic medications. Some companies in the Olanzapine market include Eli Lilly, Pfizer, Novartis, and Teva Pharmaceuticals. Show Less Read more